Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University
Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University
Hangzhou, Zhejiang, China4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection to Treat Moderate to Severe Glabellar Lines | Moderate to Severe Glabellar Lines | Recruiting | Phase 3 | 2026-09-23 | NCT06937944 | |
| Study of the Efficacy and Safety of ICP-332 in Participants With Chronic Spontaneous Urticaria | Chronic Disease, Disease Attributes, Hypersensitivity, Immediate, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, chronic urticaria, immune system disorder, skin disorder, skin vascular disease, urticaria | Recruiting | Phase 2 / Phase 3 | 2026-04-21 | NCT07378527 | |
| A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis | Plaque Psoriasis | Recruiting | Phase 1 / Phase 2 | 2025-09-10 | NCT07129382 | |
| ICP-332 in Subjects With Non-segmental Vitiligo | Non Segmental Vitiligo | Recruiting | Phase 2 / Phase 3 | 2025-08-07 | NCT07047612 |